DOCS - Doximity, Inc. Stock Analysis

Latest News

GLOBENEWSWIRE · OCT 5, 2026

Deadline Alert: Doximity, Inc. (DOCS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

LOS ANGELES, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming November 16, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Doximity, Inc. (“Doximity” or the “Company”) (NYSE: DOCS) securities between August 8, 2024 and May 13, 2026 inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR DOXIMITY, INC.

READ ARTICLE

EARLIER COVERAGE

ZACKS INVESTMENT RESEARCH · OCT 5, 2026

Reasons to Retain Doximity Stock in Your Portfolio for Now

DOCS' rapid clinical AI adoption and strong cash generation support its outlook, but tight pharma budgets and AI costs may limit near-term gains.

READ ARTICLE

GLOBENEWSWIRE · OCT 5, 2026

DOCS INVESTOR NOTICE: Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - November 16, 2026 Deadline

SAN DIEGO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Doximity, Inc. (NYSE: DOCS) common stock between August 8, 2024 and May 13, 2026, inclusive (the “Class Period”), have until November 16, 2026 to seek appointment as lead plaintiff of the Doximity class action lawsuit. Captioned Michigan Laborers' Pension Fund v.

READ ARTICLE

GLOBENEWSWIRE · OCT 5, 2026

DOCS Investor Alert: Doximity, Inc. Securities Class Action Notice - Contact Levi & Korsinsky

Important notice regarding alleged Newsfeed revenue misrepresentations: the lawsuit contends Doximity overstated how much its flagship advertising product contributed to growth while allegedly relying on the "light engagement" ad formats the Company publicly disavowed Important notice regarding alleged Newsfeed revenue misrepresentations: the lawsuit contends Doximity overstated how much its flagship advertising product contributed to growth while allegedly relying on the "light engagement" ad formats the Company publicly disavowed

READ ARTICLE

GLOBENEWSWIRE · OCT 5, 2026

Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Doximity (DOCS) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 11/16/2026

READ ARTICLE

PRNEWSWIRE · OCT 5, 2026

Doximity, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DOCS

NEW YORK, Oct. 5, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Doximity, Inc. ("Doximity" or "the Company") (NYSE: DOCS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of DOCS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

READ ARTICLE

PRNEWSWIRE · OCT 5, 2026

DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law

LOS ANGELES, Oct. 5, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. ("Doximity" or "the Company") (NYSE: DOCS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of DOCS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

READ ARTICLE

NEWSFILE CORP · OCT 4, 2026

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS

New York, New York--(Newsfile Corp. - October 4, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between August 8, 2024 and May 13, 2026, both dates inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline. SO WHAT: If you purchased Doximity common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

READ ARTICLE

NEWSFILE CORP · OCT 3, 2026

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS

New York, New York--(Newsfile Corp. - October 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between August 8, 2024 and May 13, 2026, both dates inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline. SO WHAT: If you purchased Doximity common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

READ ARTICLE

GLOBENEWSWIRE · OCT 3, 2026

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS

NEW YORK, Oct. 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between August 8, 2024 and May 13, 2026, both dates inclusive (the “Class Period”), of the important November 16, 2026 lead plaintiff deadline.

READ ARTICLE

SHOWING 2–10 OF 35

PEER	PRICE
GH	$184.79	COMPARE
VTRS	$17.71	COMPARE
RVTY	$154.84	COMPARE
SOLV	$87.50	COMPARE
TEM	$82.00	COMPARE
ICLR	$164.43	COMPARE
EHC	$121.67	COMPARE
COO	$56.59	COMPARE

KEY STATISTICS

COMPANY

LEADERSHIP

COMPENSATION 2026

ABOUT

PRICE TARGET

UPCOMING EARNINGS

ETFS HOLDING THIS STOCK

INSTITUTIONAL OWNERSHIP

PRICE

About Doximity, Inc.

INDUSTRY

A PRODUCT DOXIMITY, INC. IS KNOWN FOR

COMPETITORS

Doximity in 2025

Doximity Stock Plummets 14% Despite Crushing Q2 Earnings and Revenue Forecasts

Doximity Aggressively Expands into Clinical AI with Free Scribe Tool and Strategic Acquisition

Latest News

Deadline Alert: Doximity, Inc. (DOCS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Reasons to Retain Doximity Stock in Your Portfolio for Now

DOCS INVESTOR NOTICE: Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - November 16, 2026 Deadline

DOCS Investor Alert: Doximity, Inc. Securities Class Action Notice - Contact Levi & Korsinsky

Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Doximity, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DOCS

DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS

RATINGS SNAPSHOT

MOST RECENT ANALYST GRADES

SECTORS PEERS

TRADES BY CONGRESS

INSIDER TRADES